Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

Next Previous
Trial Profile

Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 26 Dec 2017

At a glance

  • Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use

    • Most Recent Events

    • 24 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top